<DOC>
	<DOCNO>NCT01631305</DOCNO>
	<brief_summary>The purpose study determine whether levothyroxine effective safe treatment child euthyroid sick syndrome , hospitalize pediatric intensive care unit .</brief_summary>
	<brief_title>Levothyroxine Children With Euthyroid Sick Syndrome</brief_title>
	<detailed_description>Children euthyroid sick syndrome , hospitalize pediatric intensive care unit , randomise receive either Levothyroxine placebo , determine diminishes mortality .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Euthyroid Sick Syndromes</mesh_term>
	<mesh_term>Magnesium Oxide</mesh_term>
	<criteria>All child age 1 month 17 year . Admitted pediatric intensive care unit . TSH thyroid hormone age specific level . Known thyroid condition . Brain death . Gut condition contraindicate oral route . Readmissions intensive care unit .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Euthyroid Sick Syndromes</keyword>
	<keyword>Thyroxine</keyword>
	<keyword>Intensive care</keyword>
</DOC>